Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Prince

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Experimental Hematology|January 16, 1998
Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistanceH M Prince, S Dessureault, S Gallinger, et al.
Bone Marrow Transplantation|January 1, 1995
Microbial contamination of harvested bone marrow and peripheral bloodH M Prince, S R Page, A Keating, et al.
Leukemia|January 15, 2010
Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patientsA C Chan, P Neeson, E Leeansyah, et al.
Journal of Clinical Apheresis|June 4, 1999
Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC programR Wilke, M Brettell, H M Prince, et al.
Bone Marrow Transplantation|August 26, 1998
Peripheral blood CD34+ cell count reliably predicts autograft yieldP Chapple, H M Prince, M Quinn, et al.
The British Journal of Dermatology|June 14, 2005
Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapyS Brennand, V R Sutton, J Biagi, et al.
Internal Medicine Journal|August 22, 2001
High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experienceA J Dowling, H M Prince, A Wirth, et al.
Bone Marrow Transplantation|August 3, 2010
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myelomaP A Thompson, H M Prince, J F Seymour, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2006
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinomaD Ritchie, L Mileshkin, D Wall, et al.
Bone Marrow Transplantation|August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cellsK E Herbert, P Gambell, E K Link, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Experimental Hematology|January 16, 1998
Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistanceH M Prince, S Dessureault, S Gallinger, et al.
Bone Marrow Transplantation|January 1, 1995
Microbial contamination of harvested bone marrow and peripheral bloodH M Prince, S R Page, A Keating, et al.
Leukemia|January 15, 2010
Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patientsA C Chan, P Neeson, E Leeansyah, et al.
Journal of Clinical Apheresis|June 4, 1999
Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC programR Wilke, M Brettell, H M Prince, et al.
Bone Marrow Transplantation|August 26, 1998
Peripheral blood CD34+ cell count reliably predicts autograft yieldP Chapple, H M Prince, M Quinn, et al.
The British Journal of Dermatology|June 14, 2005
Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapyS Brennand, V R Sutton, J Biagi, et al.
Internal Medicine Journal|August 22, 2001
High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experienceA J Dowling, H M Prince, A Wirth, et al.
Bone Marrow Transplantation|August 3, 2010
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myelomaP A Thompson, H M Prince, J F Seymour, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2006
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinomaD Ritchie, L Mileshkin, D Wall, et al.
Bone Marrow Transplantation|August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cellsK E Herbert, P Gambell, E K Link, et al.
Pageof 16